Leishmania spp are obligate intracellular protozoan parasites of the mononuclear phagocyte system that cause a spectrum of diseases known as leishmaniasis. Platelet Activating Factor (PAF) and some PAF-antagonists seem to playa key role in Leishmania infection. In this article we detected for the first time the specific activities of PAF basic metabolic enzymes, PAF cholinephosphotransferase (PAF-CPT) and Lyso-PAF-acetylotransferase (Lyso-PAF-AT), in two species of Leishmania, namely Leishmania major (L. major) and Leishmania injantum (L. injantum). Specific activity of PAF-CPT of L. major homogenates was substantially higher than that of L. injantum homogenates, while Lyso-PAF-AT specific activities of the homogenates of both species were detected in the same levels. In addition, PAF-like molecules were detected in cells and their culture medium of both species. These results show that PAF-biosynthesis exists and varies between Leishmania species, findings that are in correlation with the general idea that the presence of PAF in several Leishmania species is implicated in Leishmania infection.
Leishmaniasis is an endemic disease caused by approximately 21 species of the genus Leishmania (order Kinetoplastida, family Trypanosomatidae) (l). The disease is known to have a wide range of clinical symptoms ranging from simple self-cured cutaneous lesion, to severe mucocutaneous form and even to the fatal visceral form if left untreated (l). Leishmaniasis, apart from their importance for the worldwide distribution emergence of Leishmania/ HIV coinfections, have been a major cause for concern since both diseases produce a cumulative effect and thus exponentially increase disease severity (2) .
Chemotherapy has been used for the control of leishmaniasis for nearly 87 years (2) (3) . However, all chemotherapeutic drugs/agents exhibit several difficulties such as excessive toxicity, long duration of therapy etc. Thus, despite the complexities of the disease, the transposition of research targeting in finding new nontoxic agents that may contribute to the existing anti-leishmanial therapies is of great importance. A successful drug discovery was a formulation of Amphotericine B in liposomes (Ambiosome introduced in 1994). Although this formulation was highly effective with reduced toxicity, its high cost forbids its use for the majority of the poor sufferers of leishmaniasis of the Third World.
Some alkyl-Iysophospholipids and the new compounds derived from them such as Miltefosine [hexadecylphosphocholine (HePC)], showed a high efficacy against both leishmaniasis and human immunodeficiency virus-Leishmania co-infection (3) (4) , while such compounds usually inhibit also Platelet Activating Factor (PAF) through their agonistic action against PAF-binding to its receptor (PAF-R) (4) (5) (6) .
PAF (1-0-alkyl-2-acetyl-sn-glycero-3phosphocholine) is a potent phospholipid mediator of inflammation with a wide variety ofbiological activities (6) (7) . Many different cells, including blood cells, endothelial cells, protozoa, bacteria, etc. can produce PAF under appropriate stimuli (6, 8) . Two enzymatic pathways of PAF biosynthesis have been described (8) , the de novo and the remodeling pathways, with the dithiothreitol-insensitive COP-choline: 1-0alkyl-2-acetyl-sn-glycerol cholinephosphotransferase (pAF-CPT, EC 2.7.8.16) and the lyso-PAF:acetyl-CoA acetyltransferase (Lyso-PAF-AT, EC 2.3.1.67) being their basic regulatory enzymes, respectively. PAF targets these and other cells via specific, G-proteincoupled receptors to initiate intracrine, autocrine, paracrine andjuxtacrine cell activation (6) .
The physiological role ofPAF in lower eukaryotes is still largely unknown, although it has been implicated in several morphoregulatory functions (9) and in some physiological roles related to cell differentiation in trypanosomatids (10) . However, PAF induces the infection of microbes, especially to those microbes that can produce PAF (II).
PAF is also implicated in leishmaniasis, while several molecules with inhibitory effect towards PAF seem also to act beneficially in both Leishmania and HIV infections (4, (12) (13) (14) (15) (16) . However, the demonstration that PAF and its basic biosynthetic enzymes can derive also from the Leishmania parasites is a novel and previously undescribed finding.
To this end, we studied the possible production of PAF in parasite cultures of promastigotes of L. irfantum (a strain endemic in Southern Europe, including Greece, that cause mainly visceral leishmaniasis (17) (18) ) and L. major that cause cutaneous leishmaniasis in the Europe (18) , by detecting the existence ofPAF or PAF-like molecules in both parasite promastigotes and/or in the parasite free culture medium. Furthermore, detection of the specific activities of its basic biosynthetic enzymes (PAF-CPT, Lyso-PAF-AT) of the homogenates of Leishmania parasites was also carried out.
MATERIALS AND METHODS

Materials and instrumentation
Centrifugations were performed in a Heraeus Labofug 400R and a Sorvall RC-SB refrigerated superspeed centrifuge (Sigma-Aldrich, St. Louis, Mo, USA) apart from the centrifugation at IOOOOOxg, which was performed in a Heraeus -Christ, Omega 70000 ultracentrifuge (Heraeus, Hanau, Germany). Homogenizations were conducted at 40KHz with a VCSO supersonic sonicator of Sonics & Materials. (Sonics & Materials, CN, USA). Aggregation studies were performed in a Chrono-log aggregometer (model 400) (Havertown, PA, USA) coupled to a Chrono-Log recorder (Havertown, PA, USA) at 37°C with constant stirring at 1200 rpm. The electrospray ionization (ESI) mass spectrometry experiments were performed on an Electronspray MS-LCQDeca (Thermo Finnigan Ltd., Hertfordshire, UK), low flow, and mass spectrometer. Samples were dissolved in a small volume of HPLC grade methanol/water (70:30, v/v) 0.0 I M in ammonium acetate. Electrospray samples are typically introduced into the mass analyzer at a rate on f!Llmin. Nitrogen of purity 99.99% was used as nebulizing gas and as bath gas with flow rate on f!Llmin. The spectrum analysis was contacted in the ion space of SO-I SOO rn/z and the conditions for the highest intensity of the summits with the lowest rupture being those that are shown below: spray voltage: S kV, capillary voltage: 7V, capillary temperature: 27SoC, lensentrance voltage: -S4V, lens voltage: -22 V. I-O-alkyl-2sn-acetyl-glycerol (AAG) was purchased from BIOMOL 'International, (BIOMOL Int., Exeter, UK). CDP-choline, dithiothreitol (DTT), EDTA, MgCI 2 , analytical solvents, and Silica G for TLC method were purchased from Sigma (Sigma-Aldrich, Munich, Germany) and Merck (Merck, Darmstadt, Germany), respectively.
Parasite cultures
The strains MHOM/GR/78/L4A, zymodem MON-I of L. infantum, and MRHO/SU/S9/P of L. major were cultured in RPMI 1640 or D-MEM medium respectively. D-MEM or RPMI 1640 dense solution (lOx) (Biochrom, Berlin, Germany) were diluted to I: 10 with double distilled water. The solutions were supplemented with other constituents in order to achieve the following concentrations: 24 mM NaHC0 3 (Gibco, Paisley, UK), 2 mM L-glutamine and O.OS mM~-mercaptoethanol (Sigma-Aldrich, Munich, Germany), 10 mM HEPES (4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid), 
PAF and PAF-like analogue isolation and purification
A total harvesting of 1-5x10 9 leishmania parasites were centrifugated at 600 g x 10 min. The supernatant was selected and cells were washed thrice with Phosphate Buffer Solution (PBS) prepared with the addition of 8 g NaCI, 0.2 g KHl04, 0.2 g KCl and 1.16 g Na 2HP04 in 1 L of double distilled water. These salts were provided by BDH (VWR-BDH chemicals, Leicestershire, UK).
Total lipids of these cells and supernatants were extracted into chloroform according to the method of Bligh and Dyer (19) , while the separation of PAF or molecules with PAF-like activity from the lipid extracts was achieved as previously described by a TLC method on Silica Gel G in MeOH:Hp (2:1 v/v) (20) . Lipid fractions were visualized by 1 2 exposure and phospholipid products were identified by co-chromatography with known standards (semi-synthetic PAF and other lipids). PAF fractions were scraped off and extracted with chloroform according to the method of Bligh and Dyer (19) . The PAF solutions in chloroform were evaporated under a stream of nitrogen, redissolved in BSA (0.25% w/v in saline), and the produced PAF levels were estimated by biological assay based on washed rabbit platelet aggregation (7) .
Biological assay on washed rabbit platelets
PAF and the examined samples were dissolved in 2.5 mg of BSA per I mL of saline. The platelet aggregation induced by PAF (2.5 x 1011 M, final concentration) was measured as PAF-induced aggregation, in washed rabbit platelets, before (considered as 0% inhibition) and after the addition of various concentrations of the examined sample as previously described (7, 16, 21) . Consequently, the plot of percent inhibition (ranging from 0 to 100%) versus different concentrations of the sample is linear. From this curve, the concentration of the sample that inhibited 50% PAF-induced aggregation was calculated, and this value was defined as IC so ' Buffer control data were performed with 2.5 mg of BSA per 1 mL saline and the results were appropriately corrected. In addition, various concentrations of each examined sample were added into the aggregometer cuvette. According to crossdesensitization experiments that were performed, platelets were desensitized by the addition of the examined lipid at a concentration that caused reversible aggregation. Second stimulation with PAF was carried out immediately after complete disaggregation. The study was performed using a Chrono-Iog aggregometer (model 400) (Havertown, PA, USA) coupled to a Chrono-Iog recorder at 37°C with constant stirring at 1200 rpm.
ESI-MS
The electrospray ionization (ESI) mass spectrometry experiments were performed on an Electronspray MS-LCQ-Deca (Thefillo Finnigan Ltd., Hertfordshire, UK), low flow, and mass spectrometer as previously described (21) . Samples were dissolved in a small volume of HPLC grade methanol/water (70:30, v/v) 0.01 M in ammonium acetate. Electrospray samples were typically introduced into the mass analyzer at a rate of 3J.lL/min. Nitrogen of purity 99.99% was used as nebulizing gas and as bath gas with a flow rate of 3J.lL/min. The spectrum analysis was contacted in the ion space of 50-1500 m/z and the conditions for the highest intensity of the summits with the lowest rupture were the following: spray voltage: 5 kV, capillary voltage: 7 V, capillary temperature: 275°C, lens-entrance voltage: -54 V, lens voltage: -22 V.
Homogenization ofLeishmania parasites andpreparation ofsub-cellularfractions
Leishmania parasites were cultured as previously described until they reach the number of 6 x 10 7/mL parasite cells ofL. infantum and 4 x 107/mL ofL. major in stationary phase. They were separated from the medium with Centrifugation 600 g x 10 min. The supernatant was selected and cells washed with PBS thrice. Homogenization of Leishmania cells was carried out as previously described (16, 22) . Briefly, the pellet ofthe cells was resuspended in homogenization buffer containing 50 mM Tris-HCI (pH 7.4), and was homogenized by sonication in -4°e. The homogenates were centrifuged at 500xg for 10 minutes to remove nucleus, whole cells, and debris. The pellets were discarded, a small portion of the supernatants was kept for protein determination according to the Bradford method (23) and the rest of them were aliquoted and stored at -80°e. All homogenization procedures were carried out at -4°e.
DTT-insensitive PAF-Cholinephosphotransferase (PAF-CPT) activity assays
Assay was performed, as previously described (16, 22) , at 37°C for 20 min in a final volume of 200 ul, containing 0.05-0.25mg/mL protein, 100 mM Tris-HCI (pH 8.0), IS mM dithiothreitol (OTT), 0.5 mM EDTA, 20 mM MgCI 2 , I mg/mL BSA, roo IlM COP-Choline and 100 IlM I-O-alkyl-2-sn-acetyl-glycerol (AAG). The reaction was stopped by adding 2% acetic acid methanol. The extraction, purification and determination of PAF were performed as previously described (22) .
Lyso-PAF-AT activity assays
Assay was performed as previously described (16) . Briefly, the reaction was carried out at 37°C for 30 min in a final volume of 200 ul, containing 0.125mg/mL protein, 50 mM Tris-HCI (pH 7,4), 0.25mg/mL BSA, 20~lM Lyso-PAF and 200 IlM acetyl-CoA. The reaction was stopped by adding 2% acetic acid methanol and the extraction, purification and determination of PAF was carried out as mentioned in the PAF-CPT-assay (22) .
Statistical analysis
Data are expressed as mean values ± S.D using Microsoft Excel. Differences were assessed by at-test and considered to be statistically significant when p was less than 0.05. Data were analyzed using a statistical software package, SPSS 18.0 and Microsoft Excel 2007 for Windows.
RESULTS
Detection of PAF-activity in L. infantum and L. major
Tests for the biological activity similar to PAF were applied to the lipids of the culture media and washed cells from parasite cultures belonging to L. major and L. infantum species. Total lipids of these samples were separated using the method of TLC. The TLC fractions were tested for their PAF-like activity or their capacity to inhibit PAFinduced aggregation. Several series of cultures were prepared and study material was taken from different time points of the growth curve of the parasites including the logarithmic and the stationary phase of the parasite cultures. According to the TLC method of MeOH:Hp (2: 1 v/v) (20) , semisynthetic PAF used as standard, migrated in band 2 (Rf: 0.32 -0.50) (PAF fraction) whereas in band 3 (Rf 0.50 -0.75), phosphatidyl inositol is included among other biological active lipids.
Bioassay studies based on washed rabbit platelets, in the fractions derived from the TLC analysis originating from total lipids of cells and supernatants of L. major, showed that molecules with activity similar to PAF migrated on the same band with PAF standard (band 2), while those of L. infantum with activity similar to PAF migrated in band 3. In contrast, in control non-culture medium we did not detect any PAF-like activity in any bands ofTLC.
In particular, we noticed that lipids originating from total lipids of cells and supernatants of both logarithmic and stationary phases of the L. infantum parasites that migrated in the band of TLC (band 2) that PAF-standard migrates (pAF-fraction), did not exhibit biological activity on washed rabbit platelets. In addition, also lipids from cells in stationary phase that migrated in band 3 did not exhibit biological activity on washed rabbit platelets. However, lipids from cells and supernatants in logarithmic phase of the parasites and those from the supernatants of the parasite cultures in the stationary phase that migrated in band 3 (Rf 0.50 -0.75) induced aggregation of washed rabbit platelets (Fig. I) . Interestingly, the lipids that migrated in band 3 of both L. infantum supernatants and parasites' cells in Logarithmic phase exhibited higher PAF-activity when compared to the relative ones in the stationary phase, respectively (p<0.05). In addition, the lipids that migrated in band 3 of L. infantum supernatants in both Logarithmic and Stationary phases exhibited much higher PAF-activity when compared to the relative ones from parasites' cells (p<0.05 and p<0.005, respectively).
Differently from L. Infantum, lipids originating from total lipids of both cells and supernatants in stationary phases of the L. major parasites, that migrated in band 2 of the TLC, where PAF-standard also migrates (PAF-fraction), exhibited biological activity on washed rabbit platelets similar to that of the PAF-standard induced aggregation of platelets ( Figs. 2 and 3 ). In addition, desensitization and cross desensitization tests showed that these lipids with PAF-like activity also have desensitized platelets against PAF and themselves (Fig. 3) .
Moreover, lipids that migrated in band 3 induced also aggregation of washed rabbit platelets with lower effect (p<0.05) when compared to those migrated in band 2 (PAF-fraction) of the L. major parasites' cells and supernatants (Fig. 2) , but also Fig. 1 . Biological activities of lipids migrated in band 3 of TLC. expressed as nmoles of PAF that induce platelet aggregation, originated from a total harvesting of approximately N= 1-5xl0 9 parasites of L. infantum and their supe rnatants in stationary and logarithmic phase. This is a representative chart of three independent determinations, using different cultures of L. infantum . ** is referred to statistical significant differenc e with p<0.005 between lipids with PAF-acti vity ofL infantum supernatants in stationary phase compared to those from parasite cells in this growthphase. * is referred to statistical significant difference 'with p <0. 05 
between lipids with PAF-activity of L infantum supernatants in logarithmic phase comp ared to those from parasite cells in this growth-phas e. # is ref erred to statistical significant difference with p <0.05 between lipids with PAF-activity of both L infantum supernatants and parasites ' cells in logarithmic phase when compared to their relative ones in the stationary phase, respecti vely.
( 1)
(2) Fig. 2 
major samples. Representati ve charts ofdesensitization and cross-desensitization tests (c)
and (d) respectively: platelets were activated by the addition ofband 2 of TLC (pAF-ji-action) of L. major samples (el) or by PAF-standard (dl) to the platelet suspension at a concentration that caused reversible aggregation. Second stimulation with PAF-standard (c2) or band-2 ofL. major samples (d2) respectively was performed immediately after comp lete disaggregation. but re-aggregation of platelets did not take place in both cases. when compared to those lipids originating from L. infantum samples that migrated in the same band 3 ofTLC.
Although the Rf of the lipids with PAF-like activity as well as their biological characteristics were the same as those of the synthetic PAF, the lipids isolated from L. majo r samples of band 2 (PAF-fraction) were subsequently subjected to ESI-MS analysi s. The positive ESI-MS spectrum of this sample with PAF-like activity showed [M+Hr at m/z 522 , while the ions at m/z 184 and 104, which correspond to fragments of the phosphocholine moiet y, were also present (Fig. 4) . The above finding s show that the biologically active lipid present in L. majo r seems to be a PAF-Jike molecule identical to that of unsaturated PAF ( 16: I), with M. W: 521.
Detection a/specific activities ofPAF basic metabolic enzymes, PAF-CPT and Lyso-PAF-AT, in L. infantum and L. major
PAF-CPT and Lyso-PAF-AT acti vities were detected in the homogenates of both L. infantum and L. major cells of parasite-cultures in the stationary phase. Concerning a comparison of the contribution of these two enzymes' activities between these two different Leishmania species, interestingly it was found that PAF-CPT activity of the homogenates of the L. major parasites was substantially higher (lOx) corresponding to that of the L. infantum (p<0.005), whereas Lyso-PAF-AT activity of homogenates of both Leishmania species were detected in equal levels (Fig. 5 ). Con cerning a comparison of the contribution of these two enzyme s ' acti vitie s within the same Leishmania specie, PAF-CPT speci fic activity was found higher (p<0 .05) than that o f Lyso-PAF-AT in L. infantum para sites, while the opposite was observed in L. major parasites where Lyso-PAF-AT specific activity was found higher (p<0.05) compared to that of PAF-CPT in these parasites (Fig. 5 ).
Furthermore, in the absence of exogenous-added AAG substrate for the PAF-CPT assay, only the homogenate of L. major resulted in production of detectable PAE-Ievels (7.18 fmol PAF), indicating the existence of this endogenous substrate in Leishmania parasites.
DISCUSSION
Several studies have mainly focused on the effects of exogenous-added PAF in parasite cultures and/or in parasite-macrophage co-cultures during leishmaniasis (12) (13) (14) (15) . As far as we know, no studies have been carried out concerning the ability of this parasite to synthesize PAF and/or molecules with PAF-like activity. Interestingly, in another infectious protozoan-parasite, Trypanosoma cruzi an autonomous synthesis ofPAF-like lipids and their interactions with PAF-R modulate cell differentiation towards the infectious stage (24) .
In this study, we found for the first time that lipids with PAF-likeactivity exist also in both L. infantum and L. major parasites and in their culture supernatants, while PAF-basic biosynthetic enzymes' activities were found in both these Leishmania species, More specifically; our findings indicate that lipids extracted from L. major and their supernatants, that migrated in PAF-fraction (band 2) ofTLC, presented biological activities and ESI-MS spectrum similar to PAF, whereas lipids from L. infantum parasites and their supernatants that migrated in the same band 2, did not exhibit PAF-like activity. Other lipid molecules from both cell types that migrated in band 3 exhibited also a biological activity.
In addition, both PAF-basic biosynthetic enzyme activities, PAF-CPT and Lyso-PAF-AT, were detected in the homogenates of both L. major and L. infantum parasites. Furthermore, PAF-CPT activity of L. major cells was also detected when exogenous AAG (substrate for the in vitro PAF-CPT assay) was not added, indicating the endogenous existence of this substrate in these cells, which supports the existence of not only PAF-CPT of the final step but all the previous enzymes of the de novo PAF-biosynthetic pathway in Leishmania parasites.
The contribution of the two distinct PAFbiosynthetic routes seems to be associated with different functions in several organisms. In mammals for example, the de novo pathway contributes to PAF synthesis for maintaining its basal levels under physiological conditions, while the remodeling pathway is activated under inflammatory situations. However, the de novo pathway, especially PAF-CPT, may contribute to systemic disorders such as cancer (25), central nervous system failure (26) , and AIDS (27) . As far as we know there has been no previous study to give sufficient data regarding the contribution of these two distinct basic PAF biosynthetic enzymes in any protozoa.
In our study, PAF-CPT activity in L. major was significantly higher in relevance to that of L. infantum, whereas Lyso-PAF-AT activities were detected in equal levels in both Leishmania species. Interestingly, within the same Leishmania specie Lyso-PAF-AT specific activity was found higher than that of PAF-CPT in L. infantum whereas in L. Major the opposite result was observed. Such differences between the activities of PAF-key biosynthetic enzymes observed in different Leishmania parasite species seem to be correlated with their capacity to induce different immune responses and variable pathological effects;
Furthermore, since PAF-like molecules were also detected in both cells and their culture-mediums, one may suggest that synthesized PAF and/or PAFlike molecules of these parasites are transported in their environment. Among the molecules that orchestrate the interaction between Leishmania and host macrophage during leishmaniasis, PAF can be a product from either host cells participating in the inflammatory responses generated by the parasite (12) (13) (14) (15) or (according to the newly found results of this study) the initial levels of PAF implicated in these interactions could be a product of the parasite itself, giving the parasite the ability to initiate manifestations for its own aims.
In conclusion, this is the first study to report that lipid-molecules with PAF-like activity were detected in Leishmania parasites and their culture medium, but also both basic PAF-biosynthetic enzymes activities, PAF-CPT and Lyso-PAF-AT, were detected in this parasite. PAF production seems to vary between the Leishmania species tested, with the L. major exhibiting the higher capacity of PAF biosynthesis in relevance to that of the L. infantum. The findings of the present study may shed light on the inflammatory responses of all form of leishmaniasis as well as on molecules produced by different species of Leishmania that may yield innovative ideas leading to new immunotherapeutic interventions.
